Risk Factors for the Development of Secondary Malignancies After Marrow Transplantation
Authors:
- Robert P. WitherspoonRWRobert P. Witherspoon
- 1 April 1993
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 7 (2) , 417-429
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ TransplantationNew England Journal of Medicine, 1991
- CYTOGENETIC AND MOLECULAR ANALYSIS OF RELAPSE FOLLOWING BONE MARROW TRANSPLANTATIONBritish Journal of Haematology, 1990
- Secondary Cancers after Bone Marrow Transplantation for Leukemia or Aplastic AnemiaNew England Journal of Medicine, 1989
- Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid LeukemiaNew England Journal of Medicine, 1989
- Risk of Second Cancers after Treatment for Hodgkin's DiseaseNew England Journal of Medicine, 1988
- B Cell Lymphoproliferative Disorders Following T Cell Depleted Allogeneic Bone Marrow TransplantationJournal of Pediatric Hematology/Oncology, 1988
- Leukaemic transformation of engrafted bone marrow cellsBritish Journal of Haematology, 1985
- Recurrence of Ph′-Positive Leukemia in Donor Cells after Marrow Transplantation for Chronic Granulocytic LeukemiaNew England Journal of Medicine, 1984
- Radiation CarcinogenesisNew England Journal of Medicine, 1984
- Rapid Immunological Induction of Murine Lymphomas: Evidence for a Viral EtiologyScience, 1972